$QURE
uniQure N.V.
XNAS•Health Care•Pharmaceutical Preparations
$22.57
▼-3.81%-$0.894
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateWhy is QURE down today? It is at $22.57 (-3.81%), and our scanner flagged it 167 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment QURE spikes, and full due diligence on QURE — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $QURE 167 times in the last 30 days. Create a free account to track $QURE, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on QURE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for QURE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystamended. All statements other than statements of historical fact are forward-looking statements, which are often indicated by terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,”Reported Data missingness in Enroll-HD B reached 53% at Month 48Reported Mean CSF NfL was 4% above baseline for the high-doseReported Early manifest HD patients, when untreated, show a 10-, from the latest SEC filing. Read it →A share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Kapusta Matthew C Officer | Sold (automatic/other) | -21K 0.03% of company | sold 3.9% | 519K | $937K at $44.43 | Jul 2, 26 |
Kapusta Matthew C Officer | Other | 21K 0.03% of company | added 4.1% | 540K | $409K at $19.39 | Jul 2, 26 |
Kaye Jack Director | Sold (automatic/other) | -21K 0.03% of company | sold 45% | 26K | $983K at $46.43 | Jun 30, 26 |
Kaye Jack Director | Other | 21K 0.03% of company | added 97% | 43K | $427K at $20.18 | Jun 30, 26 |
Abi-Saab Walid Officer | Sold (automatic/other) | -30K 0.04% of company | sold 17% | 148K | $1.4M at $46.40 | Jun 30, 26 |
Abi-Saab Walid Officer | Other | 10K 0.01% of company | added 5.9% | 178K | $56K at $5.59 | Jun 30, 26 |
Abi-Saab Walid Officer | Sold (automatic/other) | -1K | sold 0.8% | 168K | $67K at $46.86 | Jun 26, 26 |
Kapusta Matthew C Officer | Sold (automatic/other) | -29K 0.04% of company | sold 5.2% | 519K | $1.4M at $50.02 | Jun 25, 26 |
Kapusta Matthew C Officer | Other | 29K 0.04% of company | added 5.5% | 548K | $911K at $31.71 | Jun 25, 26 |
Kapusta Matthew C Officer | Sold (automatic/other) | -7K | sold 1.3% | 519K | $335K at $50.00 | Jun 24, 26 |
Kapusta Matthew C Officer | Other | 4K | added 0.8% | 526K | $131K at $31.71 | Jun 24, 26 |
Kapusta Matthew C Officer | Sold (automatic/other) | -42K 0.06% of company | sold 7.4% | 522K | $2.1M at $50.00 | Jun 18, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on QURE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for QURE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
QURE last traded at $22.57, down 3.81% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
uniQure N.V. (QURE) is next expected to report earnings on Monday, November 9, 2026, about 34 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The QURE Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged QURE 167 times in the last 30 days.
QURE (uniQure N.V.) trades on XNAS, with a market cap of about $1.58B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge QURE for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$QURE discussion
Sign in to ask a question or join the discussion.